If my scenario in my first post today is correct I would expect the s1 filing at or around uplist. I would venture a guess that the 2.2 was necessary to pay legal and regulatory fees and other expenses related to NGIO listing.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links